Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ASP5878
i
Other names:
ASP5878, ASP 5878
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Astellas
Drug class:
FGFR1 inhibitor, FGFR4 inhibitor, FGFR2 inhibitor, FGFR3 inhibitor
Related drugs:
‹
erdafitinib (70)
surufatinib (7)
Max-40279 (2)
amlexanox (1)
HMPL-453 (1)
TT-00434 (1)
BMS-582664 (1)
FP-1039 (0)
HH185 (0)
LY2874455 (0)
OM-RCA-01 (0)
R1530 (0)
S-49076 (0)
SKI-G-801 (0)
BLU-554 (4)
H3B-6527 (3)
FGF401 (3)
ABSK012 (1)
BLU 9931 (1)
ABSK011 (1)
INCB62079 (0)
SY-4798 (0)
U3-1784 (0)
RLY-4008 (3)
ABSK061 (0)
CGT4859 (0)
DS-1123 (0)
RPT835 (0)
PBI-05204 (0)
B-701 (2)
TYRA-300 (1)
FPI-1966 (0)
LY3866288 (0)
R3Mab (0)
erdafitinib (70)
surufatinib (7)
Max-40279 (2)
amlexanox (1)
HMPL-453 (1)
TT-00434 (1)
BMS-582664 (1)
FP-1039 (0)
HH185 (0)
LY2874455 (0)
OM-RCA-01 (0)
R1530 (0)
S-49076 (0)
SKI-G-801 (0)
BLU-554 (4)
H3B-6527 (3)
FGF401 (3)
ABSK012 (1)
BLU 9931 (1)
ABSK011 (1)
INCB62079 (0)
SY-4798 (0)
U3-1784 (0)
RLY-4008 (3)
ABSK061 (0)
CGT4859 (0)
DS-1123 (0)
RPT835 (0)
PBI-05204 (0)
B-701 (2)
TYRA-300 (1)
FPI-1966 (0)
LY3866288 (0)
R3Mab (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login